William Burgan
Impact in
Papers in
-
- DNA Repair Mechanisms 5
- Heat shock proteins research 4
- Epigenetics and DNA Methylation 4
- Histone Deacetylase Inhibitors Research 4
- Protein Degradation and Inhibitors 3
- Oncology 7
- Cancer-related Molecular Pathways 3
- PARP inhibition in cancer therapy 3
- Co-authors
- Kevin Camphausen (22 shared papers)Philip J. Tofilon (21 shared papers)Michael Cerra (8 shared papers)Kelli Oswald (4 shared papers)David Cerna (6 shared papers)Hideaki Dote (4 shared papers)Jeffery S. Russell (4 shared papers)Donna Carter (5 shared papers)
- Journals
- Clinical Cancer Research (7 papers)Cancer Research (4 papers)Molecular Cancer Therapeutics (4 papers)Journal of Cellular and Molecular Medicine (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
- Partner nations
- United StatesIndiaAustralia
In The Last Decade
William Burgan
29 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 86
- Genetics 235
- Oncology 475
- Molecular Biology 1.2k
- Cancer Research 216
- Pulmonary and Respiratory Medicine 249
Countries citing papers authored by William Burgan
This map shows the geographic impact of William Burgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Burgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Burgan more than expected).
Fields of papers citing papers by William Burgan
This network shows the impact of papers produced by William Burgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Burgan. The network helps show where William Burgan may publish in the future.
Co-authors
The 25 scholars most cited alongside William Burgan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 195 | |
| 2 | 2004 | 184 | |
| 3 | 2004 | 169 | |
| 4 | Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. | 2003 | 137 |
| 5 | 2009 | 132 | |
| 6 | 2006 | 130 | |
| 7 | 2008 | 95 | |
| 8 | Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17- demethoxygeldanamycin: a multitarget approach to radiosensitization. | 2003 | 93 |
| 9 | 2008 | 88 | |
| 10 | 2004 | 81 | |
| 11 | 2005 | 80 | |
| 12 | 2009 | 76 | |
| 13 | 2009 | 71 | |
| 14 | 2005 | 43 | |
| 15 | 2006 | 40 | |
| 16 | Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of gammaH2AX foci. | 2004 | 35 |
| 17 | 2010 | 33 | |
| 18 | 2006 | 31 | |
| 19 | 2004 | 29 | |
| 20 | 2004 | 27 |
About William Burgan
William Burgan is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 1.9k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), Heat shock proteins research (4 papers), Epigenetics and DNA Methylation (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Protein Degradation and Inhibitors (3 papers), Cancer-related Molecular Pathways (3 papers), PARP inhibition in cancer therapy (3 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Genetics (235 citations), Oncology (475 citations), Molecular Biology (1.2k citations), Cancer Research (216 citations) and Pulmonary and Respiratory Medicine (249 citations). William Burgan has collaborated with scholars based in United States, India and Australia. Frequent co-authors include Kevin Camphausen, Philip J. Tofilon, Michael Cerra, Kelli Oswald, David Cerna, Hideaki Dote, Jeffery S. Russell, Donna Carter, Katie Beam and Melinda G. Hollingshead. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Molecular Cancer Therapeutics, Journal of Cellular and Molecular Medicine and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.